BAN2401 Back-up – Alzheimer’s disease

BAN2401 Back-up is a disease modifying antibody treatment for patients with early Alzheimer’s disease in partnership with Eisai. The drug candidate has a high selectivity for the toxic amyloid-beta oligomers/protofibrils.

BAN2401 Back-up is in late preclinical phase and BioArctic’s partner Eisai is driving the program towards clinical development.